GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » Accounts Payable & Accrued Expense

Anhui Anke Biotechnology (Group) Co (SZSE:300009) Accounts Payable & Accrued Expense : ¥669 Mil (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Anhui Anke Biotechnology (Group) Co Accounts Payable & Accrued Expense?

Anhui Anke Biotechnology (Group) Co's quarterly accounts payable & accrued expense declined from Mar. 2024 (¥760 Mil) to Jun. 2024 (¥704 Mil) and declined from Jun. 2024 (¥704 Mil) to Sep. 2024 (¥669 Mil).

Anhui Anke Biotechnology (Group) Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥603 Mil) to Dec. 2022 (¥636 Mil) and increased from Dec. 2022 (¥636 Mil) to Dec. 2023 (¥812 Mil).


Anhui Anke Biotechnology (Group) Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Anhui Anke Biotechnology (Group) Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Anke Biotechnology (Group) Co Accounts Payable & Accrued Expense Chart

Anhui Anke Biotechnology (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 386.42 443.57 602.73 636.20 811.52

Anhui Anke Biotechnology (Group) Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 654.42 811.52 759.70 703.92 668.59

Anhui Anke Biotechnology (Group) Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Anhui Anke Biotechnology (Group) Co Business Description

Traded in Other Exchanges
N/A
Address
No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088
Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.
Executives
Zhou Yuan Yuan Directors, executives
Wang Yong Supervisors
Yao Jian Ping Executives
Wang Rong Hai Directors, executives
Song She Wu Directors, executives
Fu Yong Biao Directors, executives
Jiang Jun Pei Supervisors
Zhao Hui Directors, executives
Xu Zhen Shan Director
Lu Guang Xin Executives
Yan Xin Wen Executives
Lu Chun Yan Executives
Wu Rui Director
Fan Qing Lin Director
Wang Yong Bin Executives

Anhui Anke Biotechnology (Group) Co Headlines

No Headlines